My thanks go to Big Tuna (and to Ekimozzir) for your latest appraisal on SSBN. Sunset Brands has retraced significantly from the recent high just over $1.90, but on several occasions, including today's session, significant support came in, and it is more than likely that the only illness or 'wasting disease' of SSBN is a shortage of news. For investors, rather than traders, that's not a big setback. Currently, the best policy is to take opportunities to add on dips.

QUES continues to collect beefy PRs, and is basically consolidating chartwise – a narrower bid-ask spread would encourage volume, and Quest has plenty of upside beckoning in Q1 of 2015. As I see it, by mid-2015 this stock is set to reach much greater recognition.